Ask AI
ProCE Banner Activity

ARRAY-520-216: Phase II Trial of Carfilzomib With or Without Filanesib in R/R MM

Slideset Download
Conference Coverage
Carfilzomib plus filanesib vs single-agent carfilzomib associated with longer median PFS for patients with pretreated R/R MM.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by independent educational grants from

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen